• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺导管原位癌的预后分类

Prognostic classification of breast ductal carcinoma-in-situ.

作者信息

Silverstein M J, Poller D N, Waisman J R, Colburn W J, Barth A, Gierson E D, Lewinsky B, Gamagami P, Slamon D J

机构信息

Gloucestershire Royal Hospital, UK.

出版信息

Lancet. 1995 May 6;345(8958):1154-7. doi: 10.1016/s0140-6736(95)90982-6.

DOI:10.1016/s0140-6736(95)90982-6
PMID:7723550
Abstract

We present a new prognostic classification designated the Van Nuys classification for ductal carcinoma-in-situ (DCIS). The classification combines high nuclear grade and comedo-type necrosis to predict clinical recurrence. Three groups of DCIS patients were defined by the presence or absence of high nuclear grade and comedo-type necrosis: 1--non-high-grade DCIS without comedo-type necrosis, 2--non-high-grade DCIS with comedo-type necrosis, 3--high-grade DCIS with or without comedo-type necrosis. There were 31 local recurrences in 238 patients after breast-conservation surgery 3.8% (3/80) in group 1, 11.1% (10/90) in group 2, and 26.5% (18/68) in group 3. The 8-year actuarial disease-free survivals were 93%, 84%, and 61%, respectively (all p < or = 0.05). The Van Nuys classification defines three distinct and easily recognisable groups, each of which has a different likelihood of local recurrence if treated with breast conservation.

摘要

我们提出了一种新的预后分类方法,即用于导管原位癌(DCIS)的范奈斯分类法。该分类法结合了高核分级和粉刺样坏死来预测临床复发情况。根据高核分级和粉刺样坏死的有无,将DCIS患者分为三组:1组——无粉刺样坏死的非高级别DCIS,2组——有粉刺样坏死的非高级别DCIS,3组——有或无粉刺样坏死的高级别DCIS。在238例行保乳手术的患者中,有31例出现局部复发,1组为3.8%(3/80),2组为11.1%(10/90),3组为26.5%(18/68)。8年无病生存率分别为93%、84%和61%(所有p≤0.05)。范奈斯分类法定义了三个不同且易于识别的组,每组如果采用保乳治疗,其局部复发的可能性各不相同。

相似文献

1
Prognostic classification of breast ductal carcinoma-in-situ.乳腺导管原位癌的预后分类
Lancet. 1995 May 6;345(8958):1154-7. doi: 10.1016/s0140-6736(95)90982-6.
2
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.病理学观点。乳腺导管原位癌:关于一种新的简化组织学分类以及细胞增殖与c-erbB-2蛋白表达之间关联的提议。
Mod Pathol. 1994 Feb;7(2):257-62.
3
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
4
Use of predictors of recurrence to plan therapy for DCIS of the breast.利用复发预测指标来规划乳腺导管原位癌的治疗方案。
Oncology (Williston Park). 1997 Mar;11(3):393-406, 409-10; discussion 413-5.
5
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.23名欧洲病理学家采用五种分类方法对乳腺导管原位癌进行分类所达到的一致性。欧盟乳腺筛查病理学工作组。
Hum Pathol. 1998 Oct;29(10):1056-62.
6
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.导管原位癌治疗后局部复发的预测因素:一项荟萃分析。
Cancer. 1999 Feb 1;85(3):616-28.
7
Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: defining cohorts for chemoprevention trials.
J Cell Biochem Suppl. 1996;25:108-11.
8
Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.乳腺导管原位癌:组织学亚型分析的可重复性
Hum Pathol. 1997 Aug;28(8):967-73. doi: 10.1016/s0046-8177(97)90013-7.
9
A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.对六种现代乳腺导管原位癌(DCIS)分类的批判性评价:与相关浸润性癌分级的相关性
Histopathology. 1996 Nov;29(5):397-409. doi: 10.1046/j.1365-2559.1996.d01-513.x.
10
Influence of local treatment on the recurrence rate of ductal carcinoma in situ.局部治疗对导管原位癌复发率的影响。
J Am Coll Surg. 1995 Jun;180(6):683-8.

引用本文的文献

1
Identification of high- and low-risk groups for ipsilateral recurrence within 10 years after breast-conserving surgery for ductal carcinoma in situ and personalized treatment: a retrospective study.保乳手术治疗导管原位癌后10年内同侧复发的高风险和低风险组识别及个体化治疗:一项回顾性研究
Gland Surg. 2025 Jul 31;14(7):1213-1229. doi: 10.21037/gs-2025-100. Epub 2025 Jul 28.
2
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications.高级别导管原位癌中Ki67高表达、HER2过表达及孕激素受体水平低:与临床实践意义的显著关联。
Front Oncol. 2025 Jan 28;15:1467664. doi: 10.3389/fonc.2025.1467664. eCollection 2025.
3
The Microenvironment in DCIS and Its Role in Disease Progression.
导管原位癌中的微环境及其在疾病进展中的作用。
Adv Exp Med Biol. 2025;1464:211-235. doi: 10.1007/978-3-031-70875-6_12.
4
Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components.高级别导管原位癌中孕酮受体水平低与HER2上调及浸润性成分的存在相关。
Front Oncol. 2024 Jun 26;14:1347166. doi: 10.3389/fonc.2024.1347166. eCollection 2024.
5
Tools to Guide Radiation Oncologists in the Management of DCIS.指导放射肿瘤学家管理导管原位癌的工具。
Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795.
6
Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study.保乳手术联合放疗治疗乳腺导管原位癌:ECOG-ACRIN E5194研究的20年结果 。 你提供的原文可能存在信息错误,根据标题推测正确的英文原文应该是“Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study.”,对应的中文译文为“乳腺导管原位癌保乳手术不联合放疗:ECOG-ACRIN E5194研究的20年结果” 。 你可以检查下原文信息,以便我为你提供更准确的翻译。 上述译文是纠正错误后按照要求为你提供的内容。
NPJ Breast Cancer. 2024 Feb 24;10(1):16. doi: 10.1038/s41523-024-00622-w.
7
Cytomorphological Assessment in Aspirates of Ductal Carcinoma in situ: Correlations with Histopathologic Grade, Architectural Pattern, and Invasion.导管原位癌穿刺标本的细胞形态学评估:与组织病理学分级、结构模式和浸润的相关性。
Acta Cytol. 2024;68(1):45-53. doi: 10.1159/000535836. Epub 2023 Dec 21.
8
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition.日本乳腺癌学会《乳腺癌病理诊断临床实践指南(2022年版)》
Breast Cancer. 2024 Jan;31(1):8-15. doi: 10.1007/s12282-023-01518-6. Epub 2023 Nov 7.
9
Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact.高级别乳腺导管原位癌(DCIS)的亚型:发生率和潜在的临床影响。
Breast Cancer Res Treat. 2023 Sep;201(2):329-338. doi: 10.1007/s10549-023-07016-9. Epub 2023 Jul 15.
10
Ductal Carcinoma in Situ: A Detailed Review of Current Practices.导管原位癌:当前诊疗实践的详细综述
Cureus. 2023 Apr 21;15(4):e37932. doi: 10.7759/cureus.37932. eCollection 2023 Apr.